MRNY
YieldMax MRNA Option Income Strategy ETF
MRNY
Closed
$34.32
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
MRNY was created on 2023-10-23 by YieldMax. The fund's investment portfolio concentrates primarily on health care equity. MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.
Company
YieldMax
Asset class
Equity
Inception date
2023
Investment segment
Health Care
ISIN
US88636X2036
Website
Key stats
Open
$32.07
Volume
561.07K
AUM
$186.56M
Prev. close
$34.42
Expense ratio
1.00%
P/E
0.00
$31.49
Day’s Range
$37.50
$14.01
52W Range
$42.39
What’s in the fund
26
Total holdings
Mrna 09/18/2026 55.01 C
64.29%
MRNA US 08/21/26 C69
31.95%
MRNA US 08/21/26 C68
31.07%
United States Treasury Bills 0%
21.30%
US DOLLARS
15.24%
United States Treasury Bills 0%
13.73%
MRNA US 08/21/26 C70
8.09%
United States Treasury Notes 2.38%
5.55%
United States Treasury Bills 0%
3.83%
Others
-95.05%
Returns
Performance
_
Difference
_
YieldMax MRNA Option Income Strategy ETF
Aug
7
Dividends
The last payment date was Aug 7, 2026
Div. per Share
$1.88
Div. Yield
5.46%
Div. Growth YoY
-39.01%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply